Local News: Malta, Malta 

 | 

Sign Up

 | 

Sign In

Pozen News Editors

News Widget

Display the Pozen news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Pozen News

News on Pozen (Ticker: POZN) continually updated from thousands of sources around the net.

Thursday Feb 2 | BioSpace

Pozen, Inc. Release: Preventive Aspirin Use Less Than Optimal in...

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia NEW ORLEANS-- --POZEN Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Aspirin (generic), Bayer, Alka-Seltzer, Medication

Thursday Feb 2 | MediLexicon

Aspirin Is Underused By Stroke Survivors

Roughly 40% of patients who survive a stroke do not take aspirin on a daily basis, despite established guidelines that recommend its use for secondary prevention in this population, investigators announced at the 2012 International Stroke Conference.

Comment?

Related Topix: Medicine, Aspirin (generic), Bayer, Alka-Seltzer, Medication, Biotech, Healthcare Industry, Chapel Hill, NC, Health

Thursday Feb 2 | Sys-Con Media

POZEN's Digital Advisory Board to Speak at Annual ePharma Summit

A POZEN-sponsored panel discussion titled, "Transforming the Pharma Industry - Breakthrough Perspectives from Digital Leaders," will be held on Tuesday, February 7, 2012 from 10:50 - 11:25 a.m. at the Sheraton New York Hotel & Towers.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing, Pharmaceutical Marketing, Healthcare Law, Law

Mon Jan 30, 2012

Local Tech Wire

Drug partnerships: Not all positive, not all negative

Pozen CEO John Platchetka likens the drug partnering process to a relay race. One runner at full speed finishes and hands the baton to another runner at full speed to finish the race.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, GlaxoSmithKline

Thu Jan 12, 2012

AmericanBankingNews.com

POZEN Inc (POZN) Posts Large Volume Increase, 375,000 Shares Trade Hands.

The stock last traded at $4.28, up from its previous close of $4.27. Separately, analysts at Brean Murray cut their price target on shares of POZEN Inc from $9.00 to $7.00 in a research note to investors on Friday, November 25th.

Comment?

Related Topix: Financial Services, Biotech, Medicine, Healthcare Industry, Wells Fargo , Banking

Also on Topix